November 2, 2026 Bonus Content: Novo Nordisk Is Bleeding Profit to Win Obesity. Amgen Isn’t. A note from our friends…
Day: November 2, 2026
You don’t need to participate on the IPO to profit
November 2, 2026 Bonus Content: Apple Reports Tonight. Margins Are the Real Story. A note from our friends at Investors…
The Smartest Investors Know This Answer…
November 2, 2026 Bonus Content: Arista Is Down 20%. Tuesday’s Numbers Will Explain It. A note from our friends at…
If You’re Within Miles of One of These Dots You Could See Your Electric Bill Increase
November 2, 2026 Bonus Content: Astera Labs Guided 40% Sequential Growth. Now Deliver. A note from our friends at Paradigm…
Novo Nordisk Is Bleeding Profit to Win Obesity. Amgen Isn’t.
With MariTide running nine Phase 3 studies, Tuesday’s earnings may be the cheapest entry into the obesity race.